Pembrolizumab (anti-PD-1)是一种有效的、高选择性的、人源IgG4-kappa单克隆抗体,同时也是抑制剂,靶向PD-1,具有潜在的免疫检查点抑制活性;MW:146.286 KD。 纯度:99%蛋白浓度:15.94mg/ml内毒素:<1EU/mg 产品名称:selleck Pembrolizumab (anti-PD-1) 单抗 ...
产品名称:selleck Pembrolizumab (anti-PD-1) 单抗 现货供应 产品货号:A2005 中文名称:派姆单抗 别名:MK-3475, lambrolizumab Selleck中国公司 生物类似抗体 现货供应,Selleck中国公司,化合物库,抑制剂,抗体,实验常用试剂,...
Nivolumab (anti-PD-1)是一种通过基因工程改造的、人类免疫球蛋白(Ig)G4单克隆抗体,靶向具有负向免疫调节功能的人类细胞表面受体程序性死亡-1(PD-1, PCD-1);也是一种抑制剂,具有免疫检查点抑制活性和抗肿瘤活性;MW:143.597 KD。上一个: 雅酶 免染PAGE凝... 下一个: Selleck 单克... 其它仪器 ...
Pembrolizumab (anti-PD-1)是一种有效的、高选择性的、人源IgG4-kappa单克隆抗体,同时也是抑制剂,靶向PD-1,具有潜在的免疫检查点抑制活性和抗肿瘤活性;MW:146.286 KD。 纯度:99%蛋白浓度:15.94mg/ml内毒素:<1EU/mg 靶点:PD-1 (Cell-free assay) ...
selleck单抗 Pembrolizumab (anti-PD-1)简要描述:产品名称:selleck单抗 Pembrolizumab (anti-PD-1)产品货号:A2005 中文名称:派姆单抗别名:MK-3475, lambrolizumabSelleck中国公司 生物类似抗体 现货供应,Selleck中国公司,化合物库,抑制剂,抗体,实验常用试剂,现货供应,欢迎咨询买生物试剂,就找华雅思创生物,生物试剂专业...
tech@selleckchem.com Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day. Certificate of Analysis Print Research Area:Immunology & InflammationPD-1/PD-L1Pembrolizumab (anti-PD-1) ...
Click to purchase the isotype control of Camrelizumab (anti-PD-1) Human IgG4 isotype control Selleck's Camrelizumab (anti-PD-1) has been cited by 1 publication Life Sci Alliance,2024,7(3)e202302368 Purity & Quality Control Batch: A201601 Purity: 99.0% Protein concentration: 3.9 mg/...
Anti-PD-L1 Ab was purchased from eBiosciences, USA; and ACY-1215, bortezomib, lenalidomide, and pomalidomide were purchased from Selleck chemicals, USA.Results Combination of anti-PD-L1 Ab (5 渭g/ml) with lenalidomide (50-100 nM) or pomalidomide (100 nM) triggered a more robust MM-...
纯度: 99% 蛋白浓度: 6.5mg/ml 内毒素: <1EU/mg。 产品名称:Anti-mouse PD-L1 (B7-H1)-InVivo 抗体 产品货号:A2115 产品品牌:Selleck Selleck 动物体内抗体 现货供应 买试剂,找华雅,生物试剂专业供应商——华雅思创生物 selleck品牌代理商——买selleck抑制剂,抗体,化合物库,就来华雅思创 产品推荐 A2108...
AIL was purchased from Nanjing DASF Biotechnology. CHX was purchased from Sigma (USA). MG-132 was purchased from Selleck (USA). An antibody against PD-L1 was purchased from Cell Signaling Technologies (CST, USA) and Abcam (USA). Anti-c-Jun was purchased from Santa Cruz Biotechnology (USA...